Deadline: 20 June 2025
The Pfizer Foundation is requesting proposals for its Fellowship Grant Program to promote the importance of training healthcare professionals to recognize, diagnose and manage ATTR cardiac amyloidosis and to foster research in this field.
Focus Areas
- It is their intent to support institutions with fellowship programs for Cardiologists or Heart Failure Advanced Practice Providers that have a strong focus on clinical practice, research and education to further the understanding of ATTR cardiac amyloidosis.
Funding Information
- Grant funding is available to support one fellow for up to a year at $80,000 USD.
Eligibility Criteria
- Accredited, US-based academic institution.
- Do not include the name of the potential fellow(s) in application materials. This grant will be awarded to an institution, not an individual.
- Institutions with fellowship programs that include independent research and a strong mentoring program. Clinical training may be included in the program but is not required.
- No aspect of the fellowship program can benefit Pfizer’s business or a Pfizer asset.
- Proposals from both established and emerging fellowships will be considered. Preference will be given to programs which have not been selected in the last 3 years or states with underserved populations.
- Examples of independent research include: observational studies and outcomes research studies where the primary focus is the scientific understanding of disease; use of screening tools and their impact on improvement of patient health.
- Examples of clinical training include: educational time with an interdisciplinary team in review of case examples and relevant didactic training as well as use of tools for improvement in patient health for specific therapeutic areas or conditions.
- Fellow time spent in the clinical setting that is supported through grant funds must not be billed as patient care.
Ineligibility Criteria
- Examples of research that would not be eligible include research involving the study and/or evaluation of any pharmaceutical product and basic science and/or fundamental research (in animal model, in-vitro, etc.).
Evaluation Criteria
- A specific grant program RFP uses an expert review panel (ERP) to make final grant decisions.
- The panels are comprised of professionals from the medical community with advanced degrees and expertise in particular clinical areas, or specific needs of a geographic region/learner group, or expertise in research, continuing professional development or quality improvement.
- Proposals will be evaluated based on the following evaluation criteria: fellowship goals, objectives, medical needs and population health, patient care experience, program criteria, mentoring, training opportunities, and resources.
For more information, visit The Pfizer Foundation.